An annual January event , where highlights will be presented from the ASH meeting. The aim of this 2 day event is to provide an overview of the breakthrough clinical data at ASH that will be useful for a UK audience. Many UK haematologists that do not have the benefit of attending ASH deem this to be a highly valuable annual event where they can hear from an expert faculty in a various disease areas. Teaching hospital staff, DGH consultants, SpRs, CNS in disease specific areas and trials unit staff.
Sessions to include: Chronic Myeloid Disease, Acute Myeloid Leukaemia, Acute Lymphoblastic Leukaemia, Multiple Myeloma, CLL, Low Grade Lymphoma, Hodgkin Lymphoma, Pathobiology and Biomarkers, High Grade Lymphoma, Rarer Entities
Register here
Email for queries: [email protected]